Cardiac Resynchronization Therapy Market: By Device, By End-User Region Forecast 2019-2030

download arrow download arrow Download Free Sample
settings arrow settings arrow email us

Cardiac Resynchronization Therapy (CRT Devices) Market Size, Share, Growth, Trends, and Global Industry Analysis: By Device (CRT-pacemakers, CRT-defibrillators), By End-User (Hospitals, Clinics, Ambulatory Surgical Centres) Region Forecast 2019-2030

checked icon arrow_drop_down
checked icon Single User License $4400 $3520
checked icon Multiple User License $6600 $5280
checked icon Corporate User License $8900 $7120

Cardiac resynchronization therapy Market size was valued at US$ 965.7 million in 2023 and is projected to reach US$ 983.4 million by 2030, registering a CAGR of 5.0% from 2024 to 2030. Cardiac Resynchronization therapy is used to treat heart diseases. Devices that are used in cardiac resynchronization therapy are known as CRT devices. Irregular heartbeats are known as arrhythmias and can be caused due to various reasons such as age, damage of the heart, genetic factors and so far used medications. CRT, or biventricular pacing, is used to improve the rhythm of the heart and reduce the symptoms that are associated with arrhythmias in heart failure patients. Heart ventricle contractions in arrhythmic patients are resynchronized by the CRT devices.

Global Cardiac Resynchronization Therapy (CRT) Market is the implantable devices with a microcomputer along with an enclosed battery by a tiny titanium metal case. Insulated wires known as leads are implanted along with the device so as to pass the information signals from the heart-to-heart device to carry electrical impulses to the heart. The CRT devices market is expected to show a significant growth rate during the forecast period due to the high prevalence of cardiac diseases.

As per the World Health Organisation (WHO), one of the leading causes of death worldwide is cardiovascular disease, and around 17.5 million people died from cardiovascular diseases which accounted for 31% of all global deaths in the year 2012. Cardiovascular diseases can be prevented by addressing behavioral risks like cigarette smoking, an unhealthy diet, and obesity, players in the market are focusing on R&D investments to improve product quality and minimize manufacturing costs, and also focus on the development of devices that are safe to improve compliance of the patient. For example, Medtronic and St. Jude Medical (Abbott laboratories) offer leadless pacemakers for the implantation of the equipment in the right ventricle. Moreover, increase in the usage of MRIs in clinical applications.

Cardiac Resynchronization Therapy (CRT) Market Key Developments

  • In February 2017, RESONATE cardiac resynchronization therapy defibrillator (CRT-D) systems were launched by Boston Scientific and also received CE Mark which is available for treatment of heart failure in patients across the globe.
  • In January 2017, Abbott Laboratories acquired St. Jude Medical, Inc., for future growth and to develop a diverse and strong portfolio of medical devices, nutritionals, diagnostics, and established branded generic pharmaceuticals.

summary download arrow Download Free Sample

Cardiac Resynchronization Therapy Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

5.0%

Largest Market

North America

Fastest Growing Market

Asia Pacific

Cardiac Resynchronization Therapy (CRT) Market Dynamics

Increase in prevalence rate of the heart diseases globally driving the CRT devices market. Rise in the demand of the invasive techniques in treatment of the heart diseases and changes in the life style driving the CRT devices market. Moreover, advancements in the technologies and rise in the adaptability of the CRT devices are fuelling the market of the CRT devices. However, risks in CRT therapy such as surgical site infection, failure in delivering the optimum therapy when it is needed (either extra therapy when it is not needed or no therapy delivered when it is needed), sensitivity towards the device material are hindering the growth of CRT devices market.

Cardiac Resynchronization Therapy Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2024-2030

Market Size in 2023

US$ 965.7 million

Market Size in 2030

US$ 983.4 million

Market CAGR

5.0%

By Type Of Device

  • CRT-pacemakers
  • CRT-defibrillators

By End User

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centres

By Region

  • North America,
  • Europe,
  • Asia-Pacific,
  • Latin America,
  • Middle East & Africa.

Key Features of the Report

  • The cardiac resynchronization therapy market report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter's Five Force Analysis in addition to recent technology advancements and innovations in the market. 
     

Download Free Sample Report

I accept the Terms and Conditions,Disclaimers, GDPR Policy

Frequently Asked Questions

The cardiac resynchronization therapy market size was valued at US$ 965.7 Mn in 2023 and is set to reach US$ 983.4 Mn by 2030 at a CAGR of 5.0% from 2024-2030

The market's key players are: Medtronic (U.S.) Abbott Laboratories (U.S.) Biotronik (Germany) LivaNova Plc. (UK) Boston Scientific Corporation (U.S.)

The market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1. Executive Summary

2. Global Cardiac Resynchronization Therapy (CRT Devices) Market Introduction

2.1. Global Cardiac Resynchronization Therapy (CRT Devices) Market Taxonomy

2.2. Global Cardiac Resynchronization Therapy (CRT Devices) Market Definitions

2.2.1. Device Type

2.2.2. End User

3. Global Cardiac Resynchronization Therapy (CRT Devices) Market Dynamics

3.1. Drivers

3.2. Restraints

3.3. Opportunities/Unmet Needs of the Market

3.4. Trends

3.5. Global Cardiac Resynchronization Therapy (CRT Devices) Market Dynamic Factors - Impact Analysis

4. Global Cardiac Resynchronization Therapy (CRT Devices) Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030

4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)

4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)

4.3. Market Opportunity Analysis

5. Global Cardiac Resynchronization Therapy (CRT Devices) Market, By Device Type, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)

5.1. CRT-pacemakers

5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)

5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.1.3. Market Opportunity Analysis

5.2. CRT-defibrillators

5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)

5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.2.3. Market Opportunity Analysis

6. Global Cardiac Resynchronization Therapy (CRT Devices) Market, By End User, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)

6.1. Hospitals

6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)

6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.1.3. Market Opportunity Analysis

6.2. Clinics

6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)

6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.2.3. Market Opportunity Analysis

6.3. Ambulatory Surgical Centers

6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)

6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

. Market Opportunity Analysis

7. Global Cardiac Resynchronization Therapy (CRT Devices) Market Forecast, By Region, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)

7.1. North America

7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)

7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.1.3. Market Opportunity Analysis

7.2. Europe

7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)

7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.2.3. Market Opportunity Analysis

7.3. Asia-Pacific

7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)

7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.3.3. Market Opportunity Analysis

7.4. Latin America

7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)

7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.4.3. Market Opportunity Analysis

7.5. Middle East and Africa

7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)

7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.5.3. Market Opportunity Analysis

7.6. Global Cardiac Resynchronization Therapy (CRT Devices) Market - Opportunity Analysis Index, By Device Type, By End User, and Region, 2024 - 2030

8. North America Cardiac Resynchronization Therapy (CRT Devices) Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)

8.1. Device Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

8.1.1. CRT-pacemakers

8.1.2. CRT-defibrillators

8.2. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

8.2.1. Hospitals

8.2.2. Clinics

8.2.3. Ambulatory Surgical Centres

8.3. Country Analysis 2016 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

8.3.1. U.S.

8.3.2. Canada

8.4. North America Cardiac Resynchronization Therapy (CRT Devices) Market - Opportunity Analysis Index, By Device Type, By End User, and Country, 2024 - 2030

8.5. North America Cardiac Resynchronization Therapy (CRT Devices) Market Dynamics – Trends

9. Europe Cardiac Resynchronization Therapy (CRT Devices) Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)

9.1. Device Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

9.1.1. CRT-pacemakers

9.1.2. CRT-defibrillators

9.2. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

9.2.1. Hospitals

9.2.2. Clinics

9.2.3. Ambulatory Surgical Centres

9.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

9.3.1. Germany

9.3.2. UK

9.3.3. France

9.3.4. Spain

9.3.5. Italy

9.3.6. Russia

9.3.7. Poland

9.3.8. Rest of Europe

9.4. Europe Cardiac Resynchronization Therapy (CRT Devices) Market - Opportunity Analysis Index, By Device Type, By End User, and Country, 2024 - 2030

9.5. Europe Cardiac Resynchronization Therapy (CRT Devices) Market Dynamics Trends

10. Asia-Pacific Cardiac Resynchronization Therapy (CRT Devices) Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)

10.1. Device Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

10.1.1. CRT-pacemakers

10.1.2. CRT-defibrillators

10.2. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

10.2.1. Hospitals

10.2.2. Clinics

10.2.3. Ambulatory Surgical Centres

10.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

10.3.1. Japan

10.3.2. China

10.3.3. India

10.3.4. ASEAN

10.3.5. Australia & New Zealand

10.3.6. Rest of Asia-Pacific

10.4. Asia-Pacific Cardiac Resynchronization Therapy (CRT Devices) Market - Opportunity Analysis Index, By Device Type, By End User, and Country, 2024 - 2030

10.5. Asia-Pacific Cardiac Resynchronization Therapy (CRT Devices) Market Dynamics  Trends

11. Latin America Cardiac Resynchronization Therapy (CRT Devices) Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)

11.1. Device Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

11.1.1. CRT-pacemakers

11.1.2. CRT-defibrillators

11.2. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

11.2.1. Hospitals

11.2.2. Clinics

11.2.3. Ambulatory Surgical Centres

11.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

11.3.1. Brazil

11.3.2. Mexico

11.3.3. Argentina

11.3.4. Venezuela

11.3.5. Rest of Latin America

11.4. Latin America Cardiac Resynchronization Therapy (CRT Devices) Market - Opportunity Analysis Index, By Device Type, By End User, and Country, 2024 - 2030

11.5. Latin America Cardiac Resynchronization Therapy (CRT Devices) Market Dynamics  Trends

12. Middle East and Africa Cardiac Resynchronization Therapy (CRT Devices) Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)

12.1. Device Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

12.1.1. CRT-pacemakers

12.1.2. CRT-defibrillators

12.2. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

12.2.1. Hospitals

12.2.2. Clinics

12.2.3. Ambulatory Surgical Centres

12.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

12.3.1. Gulf Cooperation Council (GCC) Countries

12.3.2. Israel

12.3.3. South Africa

12.3.4. Rest of MEA

12.4. MEA Cardiac Resynchronization Therapy (CRT Devices) Market - Opportunity Analysis Index, By Device Type, By End User, and Country, 2024 - 2030

12.5. MEA Cardiac Resynchronization Therapy (CRT Devices) Market Dynamics  Trends

13. Competition Landscape

13.1. Strategic Dashboard of Top Market Players

13.2. Company Profiles (Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis)

13.2.1. Medtronic (U.S.)

13.2.2. Abbott Laboratories (U.S.)

13.2.3. Biotronik (Germany)

13.2.4. LivaNova Plc. (UK)

13.2.5. Boston Scientific Corporation (U.S.)

14. Research Methodology

15. Key Assumptions and Acronyms

Key Market Players

  • Medtronic (U.S.)
  • Abbott Laboratories (U.S.)
  • Biotronik (Germany)
  • LivaNova Plc. (UK)
  • Boston Scientific Corporation (U.S.)

Related Industry Reports

Cardiac Guidewires and Catheters Market

Cardiac Markers Market

Cardiac Biomarkers Market

Global Cardiac Pacemakers Market